SGLT-2 inhibitors now first-line therapy for diabetes and CKD: new guidelines | AusDoc

Updated recommendations focus on protective benefits for the heart and kidneys Most patients with type 2 diabetes and chronic kidney disease …

Share on Facebook

Tweet

Follow us

Save